Medicare proposes limiting coverage of controversial Alzheimer's drug

Jan 13, 2022
Government insurer won't cover Aduhelm's $28,000-a-year price tag except for clinical trials.
A sign for biotechnology company, Biogen, Inc. is seen on a building in Cambridge, Massachusetts.
DOMINICK REUTER/AFP via Getty Images

FDA issues new sodium guidelines for the food industry

Oct 15, 2021
The agency recommended gradual changes to the salt content in 163 processed food categories -- aimed at lessening the amount of salt we eat.
Getty Images

FDA nears deadline to decide the fate of vapes

Sep 8, 2021
The regulator will decide whether e-cigarettes products, including those from major brands like Juul and Vuse, can stay on the market.
Vaping and e-cigarette products are displayed in a store on Dec. 19, 2019 in New York City. The FDA is closing in on making possible vaping restrictions.
Stephanie Keith/Getty Images

Who will end up paying the price for Biogen's new Alzheimer's drug?

Jun 18, 2021
The cost of the newly approved treatment will be about $56,000 a year, much of it paid for by Medicare.
Biogen’s new Alzheimer's treatment drug, Aduhelm, has an annual sticker price of $56,000.
Dominick Reuter/AFP via Getty Images

Australian company first to develop fully at-home COVID test

Dec 17, 2020
Everything needed for the test — which the FDA gave emergency authorization — is inside the box, except for a smartphone.
The Ellume COVID-19 Home Test connects directly to users’ smartphone, providing for step-by-step instructions and display of test results.
Ellume Health

Moderna asking U.S., European regulators to OK vaccine

Nov 30, 2020
Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the U.S. in December.
Joel Saget/AFP via Getty Images

Pfizer to ask today for emergency vaccine authorization

Emergency authorization means the FDA facilitates availability of the vaccine during a declared state of emergency.
An illustration picture shows vials with COVID-19 Vaccine stickers attached and syringes with the logo of pharmaceutical company Pfizer, on Nov. 17, 2020.
Justin Tallis/AFP via Getty Images

For public good, not for profit.

Support fact-based, independent journalism with a gift to Marketplace today.

FDA issues alert about accuracy of Abbott rapid COVID-19 test

The concern is that it could be returning false negative results.
For now, negative results from the Abbott test should be confirmed with another more sensitive test.
Win McNamee/Getty Images

In the COVID-19 economy, unintended consequences play a part in policymaking

A rise in domestic violence, a decline in car accidents and more.
FDA deregulation of COVID-19 antibody tests has led to a false sense of security for some, an unintended consequence of the move.
Al Bello/Getty Images

The search for tastier grocery store tomatoes is closing in

Nov 22, 2019
While identifying lost flavor genes and bringing them back has been tricky, some scientists are determined.
The flavor of tomatoes is hard to track, unlike disease.
Scott Olson/Getty Images